iHuman (NYSE:IH) Stock Price Down 0.6%

iHuman Inc. (NYSE:IHGet Free Report)’s stock price fell 0.6% during mid-day trading on Monday . The stock traded as low as $1.70 and last traded at $1.71. 846 shares traded hands during trading, a decline of 96% from the average session volume of 20,503 shares. The stock had previously closed at $1.72.

Wall Street Analyst Weigh In

Separately, TheStreet raised iHuman from a “d” rating to a “c” rating in a report on Tuesday, January 2nd.

Get Our Latest Stock Analysis on IH

iHuman Stock Performance

The stock has a market capitalization of $90.87 million, a PE ratio of 3.64 and a beta of 0.39. The stock’s 50-day moving average is $1.95 and its 200 day moving average is $2.43.

iHuman (NYSE:IHGet Free Report) last issued its quarterly earnings data on Thursday, February 29th. The company reported $0.09 earnings per share (EPS) for the quarter. iHuman had a return on equity of 20.27% and a net margin of 17.78%. The company had revenue of $35.28 million for the quarter.

iHuman Announces Dividend

The company also recently declared a — dividend, which will be paid on Wednesday, May 15th. Investors of record on Thursday, March 28th will be paid a dividend of $0.10 per share. The ex-dividend date of this dividend is Wednesday, March 27th.

iHuman Company Profile

(Get Free Report)

iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Science, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.

Recommended Stories

Receive News & Ratings for iHuman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iHuman and related companies with MarketBeat.com's FREE daily email newsletter.